Magnesium isoglycyrrhizinate
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Magnesium isoglycyrrhizinate, covering 2013-10-30 to 2017-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis B [Phase 4]